These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 2939241)

  • 1. Analogues of poison ivy urushiol. Synthesis and biological activity of disubstituted n-alkylbenzenes.
    ElSohly MA; Adawadkar PD; Benigni DA; Watson ES; Little TL
    J Med Chem; 1986 May; 29(5):606-11. PubMed ID: 2939241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of compounds structurally related to poison ivy urushiol. 4. 3-(1-Alkyl)alkylcatechols of varying side-chain shape and flexibility.
    Kurtz AP; Dawson CR
    J Med Chem; 1971 Aug; 14(8):733-7. PubMed ID: 4107135
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunologic studies of poisonous Anacardiaceae: I. Production of tolerance and desensitization to poison Ivy and oak urushiols using esterified urushiol derivatives in guinea pigs.
    Watson ES; Murphy JC; Wirth PW; Waller CW; Elsohly MA
    J Invest Dermatol; 1981 Mar; 76(3):164-70. PubMed ID: 6453903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saturated analogues of poison ivy allergens. Synthesis of trans,trans- and cis,trans-3-alkyl-1,2-cyclohexanediols and sensitizing properties in allergic contact dermatitis.
    Lepoittevin JP; Benezra C
    J Med Chem; 1986 Feb; 29(2):287-91. PubMed ID: 2936885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single dose parenteral hyposensitization to poison ivy urushiol in guinea pigs.
    Walker LA; Watson ES; elSohly MA
    Immunopharmacol Immunotoxicol; 1995 Aug; 17(3):565-76. PubMed ID: 8576546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of compounds structurally related to poison ivy urushiol. 3. 3-n-Pentadecylcatechol and 3-n-alkylcatechols of varying side-chain length.
    Kurtz AP; Dawson CR
    J Med Chem; 1971 Aug; 14(8):729-32. PubMed ID: 4107134
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on poison ivy. In vitro lymphocyte transformation by urushiol-protein conjugates.
    Dupuis G
    Br J Dermatol; 1979 Dec; 101(6):617-24. PubMed ID: 161173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urushiol detection using a profluorescent nitroxide.
    Braslau R; Rivera F; Lilie E; Cottman M
    J Org Chem; 2013 Jan; 78(2):238-45. PubMed ID: 22900824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perfluorinated analogues of poison ivy allergens. Synthesis and skin tolerogenic activity in mice.
    Fraginals R; Schaeffer M; Stampf JL; Benezra C
    J Med Chem; 1991 Mar; 34(3):1024-7. PubMed ID: 1825847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of compounds structurally related to poison ivy urushiol. V. A novel synthesis of 3-n-(1',2'-dehydrol)pentadecylcatechol (3 beta-alkylvinylcatechols) via dehydration of a bis (trimethylsilyl) intermediate.
    Kurtz AP; Dawson CR
    J Org Chem; 1972 Aug; 37(17):2767-8. PubMed ID: 4263010
    [No Abstract]   [Full Text] [Related]  

  • 11. New GLC analysis of urushiol congeners in different plant parts of poison ivy, Toxicodendron radicans.
    Craig JC; Waller CW; Billets S; Elsohly MA
    J Pharm Sci; 1978 Apr; 67(4):483-5. PubMed ID: 641754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occupational poison ivy and oak dermatitis.
    Epstein WL
    Dermatol Clin; 1994 Jul; 12(3):511-6. PubMed ID: 7923948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation and Management of Toxicodendron Dermatitis in the Emergency Department: A Review of Current Practices.
    Argo KA; Massey RC; Luth SK; Herrington JM; Lane AQ; Murray KA
    Wilderness Environ Med; 2023 Sep; 34(3):388-392. PubMed ID: 37120383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synthesis of compounds structurally related to poison ivy Urushiol. 4,5-dimethyl-3-pentadecylcatechol.
    Byck JS; Dawson CR
    J Org Chem; 1967 Apr; 32(4):1084-8. PubMed ID: 4227456
    [No Abstract]   [Full Text] [Related]  

  • 15. Allergic contact dermatitis to Ginkgo biloba L.: relationship with urushiol.
    Lepoittevin JP; Benezra C; Asakawa Y
    Arch Dermatol Res; 1989; 281(4):227-30. PubMed ID: 2774654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poison oak hyposensitization. Evaluation of purified urushiol.
    Epstein WL; Baer H; Dawson CR; Khurana RG
    Arch Dermatol; 1974 Mar; 109(3):356-60. PubMed ID: 4273614
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulation of the contact sensitivity response to urushiol with anti-urushiol monoclonal antibody ALG 991.
    Baldwin RW; Clegg JA; Curran AC; Austin EB; Khan T; Ma Y; Gunn B; Hudecz F; Byers VS; Lepoittevin JP; Price MR
    Arch Dermatol Res; 1999 Dec; 291(12):652-8. PubMed ID: 10651166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed contact sensitivity to catechols. II. Cutaneous toxicity of catechols chemically related to the active principles of poison ivy.
    Baer H; Watkins RC; Kurtz AP; Byck JS; Dawson CR
    J Immunol; 1967 Aug; 99(2):365-9. PubMed ID: 4226615
    [No Abstract]   [Full Text] [Related]  

  • 19. Delayed contact sensitivity to catechols. 3. The relationship of side-chain length to sensitizing potency of catechols chemically related to the active principles of poison ivy.
    Baer H; Watkins RC; Kurtz AP; Byck JS; Dawson CR
    J Immunol; 1967 Aug; 99(2):370-5. PubMed ID: 4226616
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.